A subset of patients with stage III colon cancer when treated with irinotecan-based therapy had improved survival rates. This is according to a new study in emGastroenterology/emsup1/sup, the official journal of the American Gastroenterological Association. When added to the standard chemotherapy treatment - fluorouracil and leucovorin - adjuvant irinotecan therapy improved overall survival rates for patients with the CpG island methylator phenotype ...
Read More
No comments:
Post a Comment